These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24861835)

  • 1. Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis.
    Dong S; Su SB
    J Integr Med; 2014 May; 12(3):147-55. PubMed ID: 24861835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis.
    Guo Y; Chen B; Chen LJ; Zhang CF; Xiang C
    J Zhejiang Univ Sci B; 2016 Nov.; 17(11):831-841. PubMed ID: 27819130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue.
    Mohsin S; Shams S; Ali Nasir G; Khan M; Javaid Awan S; Khan SN; Riazuddin S
    Differentiation; 2011 Jan; 81(1):42-8. PubMed ID: 20943307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells: potential application for the treatment of hepatic cirrhosis.
    Zhang Y; Li Y; Zhang L; Li J; Zhu C
    Stem Cell Res Ther; 2018 Mar; 9(1):59. PubMed ID: 29523186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives.
    Eom YW; Kim G; Baik SK
    World J Gastroenterol; 2015 Sep; 21(36):10253-61. PubMed ID: 26420953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanofiber-expanded stem cells mitigate liver fibrosis: Experimental study.
    Salem NA; Ahmed HH; Aglan HA; ElShebiney SA
    Tissue Cell; 2016 Oct; 48(5):544-51. PubMed ID: 27481213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.
    Xuan J; Feng W; An ZT; Yang J; Xu HB; Li J; Zhao ZF; Wen W
    Mol Cell Biochem; 2017 May; 429(1-2):113-122. PubMed ID: 28181132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.
    Berardis S; Dwisthi Sattwika P; Najimi M; Sokal EM
    World J Gastroenterol; 2015 Jan; 21(3):742-58. PubMed ID: 25624709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis.
    Baligar P; Mukherjee S; Kochat V; Rastogi A; Mukhopadhyay A
    Stem Cells; 2016 Jan; 34(1):135-47. PubMed ID: 26389810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
    Motawi TM; Atta HM; Sadik NA; Azzam M
    Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord-derived mesenchymal stem cells alleviate liver fibrosis in rats.
    Chai NL; Zhang XB; Chen SW; Fan KX; Linghu EQ
    World J Gastroenterol; 2016 Jul; 22(26):6036-48. PubMed ID: 27468195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tonsil-derived mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in mice via autophagy activation.
    Park M; Kim YH; Woo SY; Lee HJ; Yu Y; Kim HS; Park YS; Jo I; Park JW; Jung SC; Lee H; Jeong B; Ryu KH
    Sci Rep; 2015 Feb; 5():8616. PubMed ID: 25722117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells relieve fibrosis of Schistosoma japonicum-induced mouse liver injury.
    Xu H; Qian H; Zhu W; Zhang X; Yan Y; Mao F; Wang M; Xu H; Xu W
    Exp Biol Med (Maywood); 2012 May; 237(5):585-92. PubMed ID: 22678013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases.
    Wang Y; Yu X; Chen E; Li L
    Stem Cell Res Ther; 2016 May; 7(1):71. PubMed ID: 27176654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively.
    Huang B; Cheng X; Wang H; Huang W; la Ga Hu Z; Wang D; Zhang K; Zhang H; Xue Z; Da Y; Zhang N; Hu Y; Yao Z; Qiao L; Gao F; Zhang R
    J Transl Med; 2016 Feb; 14():45. PubMed ID: 26861623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment.
    Yang X; Li Q; Liu W; Zong C; Wei L; Shi Y; Han Z
    Cell Mol Immunol; 2023 Jun; 20(6):583-599. PubMed ID: 36823236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
    Jang YO; Kim MY; Cho MY; Baik SK; Cho YZ; Kwon SO
    BMC Gastroenterol; 2014 Nov; 14():198. PubMed ID: 25425284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Anti-Fibrosis Therapy with Mesenchymal Stem Cells Secreting Hepatocyte Growth Factor.
    Ishikawa H; Jo J; Tabata Y
    J Biomater Sci Polym Ed; 2012; 23(18):2259-72. PubMed ID: 22182291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis.
    Volarevic V; Nurkovic J; Arsenijevic N; Stojkovic M
    Stem Cells; 2014 Nov; 32(11):2818-23. PubMed ID: 25154380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats.
    Shao CH; Chen SL; Dong TF; Chai H; Yu Y; Deng L; Wang Y; Cheng F
    J Surg Res; 2014 Jan; 186(1):408-16. PubMed ID: 24071025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.